CD177 is a glycosylphosphatidylinositol-linked cell surface protein that is heterogeneously expressed by neutrophils, and its expression is associated with good prognosis in breast, prostate, cervical, and lung cancers (47). The gene discussed is CD177; the disease is lung cancer.